APA

Phelps R., Winston J. A., Wynn D., Habek M., Hartung H., Havrdová E. K., Markowitz G. S., Margolin D. H., Rodriguez C. E., Baker D. P. & Coles A. J. (20200616). Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Phelps Richard, Winston Jonathan A, Wynn Daniel, Habek Mario, Hartung Hans-Peter, Havrdová Eva Kubala, Markowitz Glen S, Margolin David H, Rodriguez Claudio E, Baker Darren P and Coles Alasdair J. 20200616. Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Phelps R., Winston J. A., Wynn D., Habek M., Hartung H., Havrdová E. K., Markowitz G. S., Margolin D. H., Rodriguez C. E., Baker D. P. and Coles A. J. (20200616). Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Phelps Richard, Winston Jonathan A, Wynn Daniel, Habek Mario, Hartung Hans-Peter, Havrdová Eva Kubala, Markowitz Glen S, Margolin David H, Rodriguez Claudio E, Baker Darren P and Coles Alasdair J. Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England). 20200616.